TCRT

Alaunos Therapeutics, Inc. - Common Stock (TCRT)

About Alaunos Therapeutics, Inc. - Common Stock (TCRT)

Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Fort Lauderdale, FL.

Details

Daily high

$4.42

Daily low

$4.15

Price at open

$4.25

52 Week High

$6.20

52 Week Low

$1.31

Market cap

9.4M

Dividend yield

0.00%

Volume

48,377

Avg. volume

65,873

P/E ratio

-1.82

Alaunos Therapeutics, Inc. - Common Stock News